Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Author
Log in
Sign up
DQ
David Quintela
Author with expertise in Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
Achievements
This user has not unlocked any achievements yet.
Key Stats
Upvotes received:
0
Publications:
5
(20% Open Access)
Cited by:
0
h-index:
3
/
i10-index:
0
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Overview
Publications
5
Peer Reviews
Comments
Grants
Publications
0
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups
Susana Vives
et al.
Nov 30, 2024
Patients with relapsed/refractory (R/R) AML with
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma
Gloria Iacoboni
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Immunotherapy May be Preferable to Chemotherapy As Second-Line Treatment for POD24 Follicular Lymphoma (FL) Patients
Ángel Serna
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Artificial-Intelligence, Data-Driven, Comprehensive Classification of Myeloid Neoplasms Based on Genomic, Morphological and Histological Features
Luca Lanino
et al.
Nov 5, 2024
Artificial Intelligence
Immunology
0
Paper
Artificial Intelligence
Immunology
0
Save
0
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)
Luca Lanino
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save